Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Erik J.M. van Bommel"'
Autor:
Michaël J.B. van Baar, Erik J.M. van Bommel, Daan J. Touw, Max Nieuwdorp, Jaap A. Joles, Merle M. Krebber, Petter Bjornstad, Daniël H. van Raalte
Publikováno v:
van Baar, M J B, van Bommel, E J M, Touw, D J, Nieuwdorp, M, Joles, J A, Krebber, M M, Bjornstad, P & van Raalte, D H 2023, ' Acute Effects of Insulin Infusion on Kidney Hemodynamic Function in People With Type 2 Diabetes and Normal Kidney Function ', Kidney International Reports, vol. 8, no. 4, pp. 916-920 . https://doi.org/10.1016/j.ekir.2023.01.001
Kidney Int Rep
Kidney International Reports, 8(4), 916-920. ELSEVIER SCIENCE INC
Kidney International Reports, 8(4), 916-920. Elsevier Inc.
Kidney Int Rep
Kidney International Reports, 8(4), 916-920. ELSEVIER SCIENCE INC
Kidney International Reports, 8(4), 916-920. Elsevier Inc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d2a6c493edcbcdc2567cba340a7c18
https://research.vumc.nl/en/publications/e7bd7a24-40c9-40f4-a5a0-539442f50a78
https://research.vumc.nl/en/publications/e7bd7a24-40c9-40f4-a5a0-539442f50a78
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function
Autor:
Danii L.S. Suijk, Michaël J.B. van Baar, Erik J.M. van Bommel, Zainab Iqbal, Merle M. Krebber, Volker Vallon, Daan Touw, Ewout J. Hoorn, Max Nieuwdorp, Mark M.H. Kramer, Jaap A. Joles, Petter Bjornstad, Daniël H. van Raalte
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN, 17(5), 663-671. AMER SOC NEPHROLOGY
Clinical Journal of the American Society of Nephrology, 17(5), 663-671. American Society of Nephrology
Clin J Am Soc Nephrol
Clinical journal of the American Society of Nephrology, 17(5), 663-671. American Society of Nephrology
Clinical Journal of the American Society of Nephrology, 17(5), 663-671. American Society of Nephrology
Clin J Am Soc Nephrol
Clinical journal of the American Society of Nephrology, 17(5), 663-671. American Society of Nephrology
Background and objectives Sodium-glucose transporter 2 (SGLT2) inhibitor–induced uric acid lowering may contribute to kidney-protective effects of the drug class in people with type 2 diabetes. This study investigates mechanisms of plasma uric acid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3f093cfe410e80a96d74efcfec213ab
https://research.rug.nl/en/publications/027ee923-755b-4586-b6ed-604fedf8fee8
https://research.rug.nl/en/publications/027ee923-755b-4586-b6ed-604fedf8fee8
Autor:
Anne C. Hesp, Mark M. Smits, Erik J.M. van Bommel, Marcel H.A. Muskiet, Lennart Tonneijck, Max Nieuwdorp, Mark H.H. Kramer, Jaap A. Joles, Petter Bjornstad, Daniël H. van Raalte
Publikováno v:
Journal of Diabetes and its Complications, 36(3):108127. Elsevier Inc.
Hesp, A C, Smits, M M, van Bommel, E J M, Muskiet, M H A, Tonneijck, L, Nieuwdorp, M, Kramer, M H H, Joles, J A, Bjornstad, P & van Raalte, D H 2022, ' Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes : Analysis of three clinical trials ', Journal of Diabetes and its Complications, vol. 36, no. 3, 108127 . https://doi.org/10.1016/j.jdiacomp.2022.108127
Journal of diabetes and its complications, 36(3):108127. Elsevier Inc.
Hesp, A C, Smits, M M, van Bommel, E J M, Muskiet, M H A, Tonneijck, L, Nieuwdorp, M, Kramer, M H H, Joles, J A, Bjornstad, P & van Raalte, D H 2022, ' Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes : Analysis of three clinical trials ', Journal of Diabetes and its Complications, vol. 36, no. 3, 108127 . https://doi.org/10.1016/j.jdiacomp.2022.108127
Journal of diabetes and its complications, 36(3):108127. Elsevier Inc.
Aims: Glomerular hyperfiltration plays a key role in the pathophysiology of diabetic kidney disease (DKD). Mechanisms underlying this adverse hemodynamic profile are incompletely understood. We hypothesized that systemic vascular pathology, including
Autor:
Emil List Larsen, Frank Geurts, Max Nieuwdorp, Marcel H.A. Muskiet, Daan J Touw, Henrik E. Poulsen, A.H. Jan Danser, Ewout J. Hoorn, Anna L. Emanuel, Daniël H. van Raalte, Erik J.M. van Bommel, Jaap A. Joles, Andrea Bozovic, Michaël J.B. van Baar, Mark M. Smits, Lennart Tonneijck, Mark H.H. Kramer
Publikováno v:
Kidney International, 97(1), 202-212. ELSEVIER SCIENCE INC
Kidney international, 97(1), 202-212. Nature Publishing Group
Kidney International, 97(1), 202-212. Elsevier Inc.
van Bommel, E J M, Muskiet, M H A, van Baar, M J B, Tonneijck, L, Smits, M M, Emanuel, A L, Bozovic, A, Danser, A H J, Geurts, F, Hoorn, E J, Touw, D J, Larsen, E L, Poulsen, H E, Kramer, M H H, Nieuwdorp, M, Joles, J A & van Raalte, D H 2020, ' The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial ', Kidney International, vol. 97, no. 1, pp. 202-212 . https://doi.org/10.1016/j.kint.2019.09.013
Kidney International, 97(1), 202-212. Nature Publishing Group
Kidney international, 97(1), 202-212. Nature Publishing Group
Kidney International, 97(1), 202-212. Elsevier Inc.
van Bommel, E J M, Muskiet, M H A, van Baar, M J B, Tonneijck, L, Smits, M M, Emanuel, A L, Bozovic, A, Danser, A H J, Geurts, F, Hoorn, E J, Touw, D J, Larsen, E L, Poulsen, H E, Kramer, M H H, Nieuwdorp, M, Joles, J A & van Raalte, D H 2020, ' The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial ', Kidney International, vol. 97, no. 1, pp. 202-212 . https://doi.org/10.1016/j.kint.2019.09.013
Kidney International, 97(1), 202-212. Nature Publishing Group
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve hard renal outcomes in type 2 diabetes. This is possibly explained by the fact that SGLT2i normalize the measured glomerular filtration rate (mGFR) by increasing renal vascular resistance, as
Autor:
Mark H.H. Kramer, Adrian Post, Ele Ferrannini, Marcel H.A. Muskiet, Erik J.M. van Bommel, Daniël H. van Raalte, Daan J Touw, Stephan J. L. Bakker, Max Nieuwdorp, Jaap A. Joles, Frank Geurts, Miranda van Berkel, Ewout J. Hoorn, A.H. Jan Danser
Publikováno v:
Clinical science (London, England, 134(23), 3107-3118. Portland Press Ltd.
Clinical Science, 134(23), 3107-3118. Portland Press, Ltd.
Clinical Science, 134, 23, pp. 3107-3118
Clinical science (London, England : 1979), 134(23), 3107-3118
Clinical Science, 134, 3107-3118
van Bommel, E J M, Geurts, F, Muskiet, M H A, Post, A, Bakker, S J L, Danser, A H J, Touw, D J, van Berkel, M, Kramer, M H H, Nieuwdorp, M, Ferrannini, E, Joles, J A, Hoorn, E J & van Raalte, D H 2020, ' SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes ', Clinical science (London, England : 1979), vol. 134, no. 23, pp. 3107-3118 . https://doi.org/10.1042/CS20201274
Clinical Science, 134(23), 3107-3118. PORTLAND PRESS LTD
Clinical Science, 134(23), 3107-3118. Portland Press, Ltd.
Clinical Science, 134, 23, pp. 3107-3118
Clinical science (London, England : 1979), 134(23), 3107-3118
Clinical Science, 134, 3107-3118
van Bommel, E J M, Geurts, F, Muskiet, M H A, Post, A, Bakker, S J L, Danser, A H J, Touw, D J, van Berkel, M, Kramer, M H H, Nieuwdorp, M, Ferrannini, E, Joles, J A, Hoorn, E J & van Raalte, D H 2020, ' SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes ', Clinical science (London, England : 1979), vol. 134, no. 23, pp. 3107-3118 . https://doi.org/10.1042/CS20201274
Clinical Science, 134(23), 3107-3118. PORTLAND PRESS LTD
Sodium–glucose transporter (SGLT)2 inhibitors increase plasma magnesium and plasma phosphate and may cause ketoacidosis, but the contribution of improved glycemic control to these observations as well as effects on other electrolytes and acid–bas
Autor:
Erik J.M. van Bommel, Jaap A. Joles, Marcel H.A. Muskiet, E.H. Serné, Mark M. Smits, Daniël H. van Raalte, Anne C. Hesp, Emma J. Bouman
Publikováno v:
Bouman, E J, Smits, M M, van Bommel, E J, Muskiet, M H A, Hesp, A C, Serne, E H, Joles, J A & van Raalte, D H 2021, ' Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross-sectional study ', Microcirculation, vol. 28, no. 6, e12700 . https://doi.org/10.1111/micc.12700, https://doi.org/10.1111/micc.12700
Microcirculation, 28(6):e12700. Wiley-Blackwell
Microcirculation (New York, N.y. : 1994)
Microcirculation, 28(6):e12700. Wiley-Blackwell
Microcirculation (New York, N.y. : 1994)
Objective: Diabetic kidney disease is a microvascular complication of diabetes. Here, we assessed the association between skin microvascular function and renal hemodynamic function in a cohort of well-phenotyped adults with type 2 diabetes (T2D). Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5abb16c99d143216294d67810ccd7142
https://research.vumc.nl/en/publications/7ff8ac4d-014f-4e62-bc93-807acbeba62c
https://research.vumc.nl/en/publications/7ff8ac4d-014f-4e62-bc93-807acbeba62c
Autor:
Michaël J.B. van Baar, Erik J.M. van Bommel, Mark M. Smits, Daan J. Touw, Max Nieuwdorp, Reinier W. ten Kate, Jaap A. Joles, Daniël H. van Raalte
Publikováno v:
Journal of diabetes and its complications, 36(4):108166. Elsevier Inc.
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 36(4):108166. ELSEVIER SCIENCE INC
van Baar, M J B, van Bommel, E J M, Smits, M M, Touw, D J, Nieuwdorp, M, ten Kate, R W, Joles, J A & van Raalte, D H 2022, ' Whole-body insulin clearance in people with type 2 diabetes and normal kidney function : Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity ', Journal of Diabetes and its Complications, vol. 36, no. 4, 108166 . https://doi.org/10.1016/j.jdiacomp.2022.108166
Journal of Diabetes and its Complications, 36(4):108166. Elsevier Inc.
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 36(4):108166. ELSEVIER SCIENCE INC
van Baar, M J B, van Bommel, E J M, Smits, M M, Touw, D J, Nieuwdorp, M, ten Kate, R W, Joles, J A & van Raalte, D H 2022, ' Whole-body insulin clearance in people with type 2 diabetes and normal kidney function : Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity ', Journal of Diabetes and its Complications, vol. 36, no. 4, 108166 . https://doi.org/10.1016/j.jdiacomp.2022.108166
Journal of Diabetes and its Complications, 36(4):108166. Elsevier Inc.
OBJECTIVE: Kidney insulin clearance, proposed to be the main route of extra-hepatic insulin clearance, occurs in tubular cells following glomerular filtration and peritubular uptake, a process that may be impaired in people with type 2 diabetes (T2D)
Autor:
Daniël H. van Raalte, Melanie van Nieuwenhuijzen, Nel Willekes, Erik J.M. van Bommel, Isabel T.N. Nguyen, Jaap A. Joles, Rosalie A. Scholtes
Publikováno v:
Kidney International Reports, 5(11), 2052-2054. Elsevier Inc.
Kidney International Reports
Scholtes, R A, Nguyen, I T N, van Bommel, E J M, Willekes, N, van Nieuwenhuijzen, M, van Raalte, D H & Joles, J A 2020, ' Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors ', Kidney International Reports, vol. 5, no. 11, pp. 2052-2054 . https://doi.org/10.1016/j.ekir.2020.09.002
Kidney International Reports
Scholtes, R A, Nguyen, I T N, van Bommel, E J M, Willekes, N, van Nieuwenhuijzen, M, van Raalte, D H & Joles, J A 2020, ' Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors ', Kidney International Reports, vol. 5, no. 11, pp. 2052-2054 . https://doi.org/10.1016/j.ekir.2020.09.002
Para-aminohippuric acid (PAH)-derived effective renal plasma flow (ERPF) is increasingly being used in parallel with the revived interest in kidney hemodynamic function due to the development of sodium glucose co-transporter 2 (SGLT2) inhibitors. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2217aa8cef4825af92e02b3b415018b
https://research.vumc.nl/en/publications/50112c20-3e8d-4517-b5d5-e1751032f0e3
https://research.vumc.nl/en/publications/50112c20-3e8d-4517-b5d5-e1751032f0e3
Autor:
Kristien E. C. Bouter, Henk Schierbeek, Max Nieuwdorp, Mireille J. Serlie, Mariëtte T. Ackermans, Alinda W. M. Schimmel, Geesje M. Dallinga-Thie, Dewi van Harskamp, Hans Jansen, Daniël H. van Raalte, Erik J.M. van Bommel
Publikováno v:
Diabetes, obesity & metabolism, 22(6), 988-996. Wiley-Blackwell
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism
Aim To dissect the effects of the sodium-glucose linked transporter 2 inhibitor dapagliflozin on lipid metabolism and assess whether these effects could potentially offset cardiovascular benefit with this drug-class. Materials and methods We assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f19ba8a7f3f9b51f0595e2a2edafb75e
https://pure.amc.nl/en/publications/the-effect-of-dapagliflozin-on-apolipoprotein-b-and-glucose-fluxes-in-patients-with-type-2-diabetes-and-wellcontrolled-plasma-ldl-cholesterol(86244dc5-b356-4d2e-bd37-19623bdfc690).html
https://pure.amc.nl/en/publications/the-effect-of-dapagliflozin-on-apolipoprotein-b-and-glucose-fluxes-in-patients-with-type-2-diabetes-and-wellcontrolled-plasma-ldl-cholesterol(86244dc5-b356-4d2e-bd37-19623bdfc690).html
Autor:
Nora M. Fagan, Audrey Koitka-Weber, Yuliya Lytvyn, Bruce A. Perkins, Nima Soleymanlou, Erik J.M. van Bommel, Jaap A. Joles, Daniël H. van Raalte, David Z.I. Cherney
Publikováno v:
van Bommel, E J M, Lytvyn, Y, Perkins, B A, Soleymanlou, N, Fagan, N M, Koitka-Weber, A, Joles, J A, Cherney, D Z I & van Raalte, D H 2020, ' Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function ', Kidney International, vol. 97, no. 4, pp. 631-635 . https://doi.org/10.1016/j.kint.2019.12.021
Kidney International, 97(4), 631-635. Nature Publishing Group
Kidney International, 97(4), 631-635. Nature Publishing Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a095361c0f9e12a906b15c95348969f
https://research.vumc.nl/en/publications/054240d6-2d8a-4458-a79a-76a14052825e
https://research.vumc.nl/en/publications/054240d6-2d8a-4458-a79a-76a14052825e